Will the Moderna share price ever recover? - Mentor Finance episode artwork

EPISODE · May 25, 2022 · 8 MIN

Will the Moderna share price ever recover? - Mentor Finance

from Procommun · host Procommun

Moderna (NASDAQ:MRNA) shares traded for more than $450 last summer. But today the stock is trading at $136 – less than a third of its pandemic peak. The vaccine-maker stock gained massively during the pandemic. Its mRNA vaccine was favoured by governments around the world, including in the US and EU. Continue reading on procommun.com

Moderna (NASDAQ:MRNA) shares traded for more than $450 last summer. But today the stock is trading at $136 – less than a third of its pandemic peak. The vaccine-maker stock gained massively during the pandemic. Its mRNA vaccine was favoured by governments around the world, including in the US and EU. Continue reading on procommun.com

NOW PLAYING

Will the Moderna share price ever recover? - Mentor Finance

0:00 8:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Procommun?

This episode is 8 minutes long.

When was this Procommun episode published?

This episode was published on May 25, 2022.

What is this episode about?

Moderna (NASDAQ:MRNA) shares traded for more than $450 last summer. But today the stock is trading at $136 – less than a third of its pandemic peak. The vaccine-maker stock gained massively during the pandemic. Its mRNA vaccine was favoured by...

Can I download this Procommun episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!